The direct effect of hyperosmolar agents on ciliary beating of human bronchial epithelial cells

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 25, Issue 2, 2012, Pages 88-95

  Yaghi, Asma ^a,b   Zaman, Aisha ^a,b   Dolovich, Myrna B ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

bronchial cilia; cilia function; dextran; high speed digital imaging; human; mannitol; osmolarity; saline

Indexed keywords

DEXTRAN; MANNITOL; SODIUM CHLORIDE;

ARTICLE; BRONCHIAL EPITHELIAL CELL; CELLULAR PARAMETERS; CILIAY BEAT FREQUENCY; EPITHELIUM CELL; EUKARYOTIC FLAGELLUM; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROSCOPY; OSMOLARITY;

AGED; AGED, 80 AND OVER; BRONCHI; CILIA; DEXTRANS; EPITHELIAL CELLS; HUMANS; MANNITOL; MIDDLE AGED; OSMOLAR CONCENTRATION; SODIUM CHLORIDE; TIME FACTORS;

EID: 84859392118     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0914     Document Type: Article

References (43)

1. Rutland J, Griffin WM, and Cole PJ: Human ciliary beat frequency in epithelium from intrathoracic and extrathoracic airways. Am Rev Respir Dis. 1982;125:100-105.
2. Yager JA, Ellman H, and Dulfano MJ: Human ciliary beat frequency at three levels of the tracheobronchial tree. Am Rev Respir Dis. 1980;121:661-665.
3. Wanner A, Salathe M, and ORiordan TG: Mucociliary clearance in the airways. Am J Respir Crit Care Med. 1996; 154(Pt 1):1868-1902.
4. Braiman A, and Priel Z: Efficient mucociliary transport relies on efficient regulation of ciliary beating. Respir Physiol Neurobiol. 2008;163:202-207.
5. Tarran R, Donaldson S, and Boucher RC: Rationale for hypertonic saline therapy for cystic fibrosis lung disease. Semin Respir Crit Care Med. 2007;28:295-302.
6. Daviskas E, Robinson M, Anderson SD, and Bye PT: Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction. J Aerosol Med. 2002;15:331-341.
7. Daviskas E, and Anderson SD: Hyperosmolar agents and clearance of mucus in the diseased airway. J Aerosol Med. 2006;19:100-109.
8. Bilton D, Robinson P, Cooper P, Gallagher CG, Kolbe J, Fox H, Jaques A, and Charlton B: Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study. Eur Respir J. 2011;38:1071-1080.
9. Daviskas E, Anderson SD, Brannan JD, Chan HK, Eberl S, and Bautovich G: Inhalation of dry-powder mannitol increases mucociliary clearance. Eur Respir J. 1997;10:2449-2454.
10. Daviskas E, Anderson SD, Eberl S, Chan HK, and Bautovich G: Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am J Respir Crit Care Med. 1999;159:1843-1848.
11. Daviskas E, Anderson SD, Eberl S, Chan HK, and Young IH: The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest. 2001;119:414-421.
12. Daviskas E, Anderson SD, Gomes K, Briffa P, Cochrane B, Chan HK, Young IH, and Rubin BK: Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum. Respirology. 2005;10:46-56.
13. Robinson M, Daviskas E, Eberl S, Baker J, Chan HK, Anderson SD, and Bye PT: The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur Respir J. 1999;14:678-685.
14. Boek WM, Keles N, Graamans K, and Huizing EH: Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope. 1999;109:396-399.
15. Min YG, Lee KS, Yun JB, Rhee CS, Rhyoo C, Koh YY, Yi WJ, and Park KS: Hypertonic saline decreases ciliary movement in human nasal epithelium in vitro. Otolaryngol Head Neck Surg. 2001;124:313-316.
16. Pavia D, Thomson ML, and Clarke SW: Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis. 1978;117: 199-203.
17. Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, and Bye PT: Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax. 1997;52:900-903.
18. Luk CK, and Dulfano MJ: Effect of pH, viscosity and ionicstrength changes on ciliary beating frequency of human bronchial explants. Clin Sci (Lond). 1983;64:449-451.
19. Winters SL, Davis CW, and Boucher RC: Mechanosensitivity of mouse tracheal ciliary beat frequency: roles for Ca2 + , purinergic signaling, tonicity, and viscosity. Am J Physiol Lung Cell Mol Physiol. 2007;292:L614-L624.
20. Yaghi A, Zaman A, and Dolovich M: The direct effect of hyperosmolar agents on ciliary function of human. bronchial epithelial cells. Am J Respir Crit Care Med. 2009;179:A1212.
21. Rossman CM, Forrest JB, Lee RM, and Newhouse MT: The dyskinetic cilia syndrome. Ciliary motility in immotile cilia syndrome. Chest. 1980;78:580-582.
22. Motulskey H. Intuitive Biostatistics. 1995 ed. Oxford University Press, New York; 1995.
23. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, and Boucher RC: Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006;354:241-250.
24. Jaques A, Daviskas E, Turton JA, McKay K, Cooper P, Stirling RG, Robertson CF, Bye PT, Lesouef PN, Shadbolt B, Anderson SD, and Charlton B: Inhaled mannitol improves lung function in cystic fibrosis. Chest. 2008;133:1388-1396.
25. Daviskas E, Anderson SD, Eberl S, Young IH: Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis. Eur Respir J. 2008;31:765-772.
26. Tarran R, Grubb BR, Parsons D, Picher M, Hirsh AJ, Davis CW, and Boucher RC. The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell 2001;8: 149-158.
27. Feng W, Nakamura S, Sudo E, Lee MM, Shao A, and King M: Effects of dextran on tracheal mucociliary velocity in dogs in vivo. Pulm Pharmacol Ther. 1999;12:35-41.
28. Daviskas E, Anderson SD, and Young IH: Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis. Respir Med. 2010;104:371-377.
29. Glover W, Chan HK, Eberl S, Daviskas E, and Anderson S: Lung deposition of mannitol powder aerosol in healthy subjects. J Aerosol Med. 2006;19:522-532.
30. Olson DE, Dart GA, and Filley GF: Pressure drop and fluid flow regime of air inspired into the human lung. J Appl Physiol. 1970;28:482-494.
31. Wills PJ, Hall RL, Chan W, and Cole PJ: Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest. 1997;99:9-13.
32. Winters SL,Yeates DB. Roles of hydration, sodium, and chloride in regulation of canine mucociliary transport system. J Appl Physiol. 1997;83:1360-1369.
33. Nilsson H, Dragomir A, Ahlander A, Johannesson M, and Roomans GM: Effects of hyperosmotic stress on cultured airway epithelial cells. Cell Tissue Res. 2007;330:257-269.
34. Brannan JD, Gulliksson M, Anderson SD, Chew N, and Kumlin M: Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J. 2003;22: 491-496.
35. Wanner A, Maurer D, Abraham WM, Szepfalusi Z, and Sielczak M: Effects of chemical mediators of anaphylaxis on ciliary function. J Allergy Clin Immunol. 1983;72:663-667.
36. Wanner A, Sielczak M, Mella JF, and Abraham WM: Ciliary responsiveness in allergic and nonallergic airways. J Appl Physiol. 1986;60:1967-1971.
37. Wong LB, Miller IF, and Yeates DB: Regulation of ciliary beat frequency by autonomic mechanisms: in vitro. J Appl Physiol. 1988;65:1895-1901.
38. Nemeth ZH, Deitch EA, Szabo C, and Hasko G: Hyperosmotic stress induces nuclear factor-kappaB activation and interleukin-8 production in human intestinal epithelial cells. Am J Pathol. 2002;161:987-996.
39. Allen-Gipson DS, Romberger DJ, Forget MA, May KL, Sisson JH, and Wyatt TA: IL-8 inhibits isoproterenol-stimulated ciliary beat frequency in bovine bronchial epithelial cells. J Aerosol Med. 2004;17:107-115.
40. Leuppi JD, Brannan JD, and Anderson SD: Bronchial provocation tests: the rationale for using inhaled mannitol as a test for airway hyperresponsiveness. Swiss Med Wkly. 2002; 132:151-158.
41. Pilcer G, and Amighi K: Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm. 2010; 392:1-19.
42. Patton JS, Byron PR: Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6: 67-74.
43. Kaialy W, Martin GP, Ticehurst MD, Momin MN, and Nokhodchi A: The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient. Int J Pharm. 2010;392:178-188.